#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune thrombocytopenia Arteriovenous malformation Atopic keratoconjunctivitis Metastatic gastric cancer Chronic hepatitis B Non-Hodgkin's lymphoma Pulmonary fibrosis Post transplant lymphoproliferative disorder Encephalitis autoimmune Thrombotic thrombocytopenic purpura Craniopharyngioma Malformation venous Mucous membrane pemphigoid Malignant peritoneal neoplasm Nephroblastoma More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Life with Disease Adrenogenital syndrome – Basic Information Pemphigoid – Trials in Disease Retinoblastoma – Life with Disease Skin angiosarcoma – Treatment Burkitt’s lymphoma – Treatment Andersen-Tawil syndrome – Life with Disease Isodicentric chromosome 15 syndrome – Trials in Disease Leukoencephalopathy – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elamipretide Trihydrochloride Mocravimod Dinutuximab Beta VINBLASTINE Resiquimod Sulfate Itacitinib Nipocalimab Botensilimab Bleomycin Ketamine Crofelemer Disodium Levofolinate [18F]Fluoro-Peg-Folate Imatinib Rtp-026 Sodium Ivabradine Amlitelimab GRISNILIMAB SETARITOX Rozanolixizumab Gd2Il18Cart More therapies…

    Learn about Your Condition

    Muscle strain Trisomy 21 Neuropathic arthropathy Atrophic vulvovaginitis Hypertonic bladder Open angle glaucoma Familial mediterranean fever Multiple system atrophy Fibrous dysplasia of bone K-ras gene mutation Mantle cell lymphoma stage II Short stature Crohn's disease Lymphangioma Bipolar I disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Ivonescimab to FOLFOX Drug Combination for Patients with Advanced Biliary Tract Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Calcium Levofolinate
    • Ivonescimab
    • Calcium Folinate
    France

  • Study on the Effectiveness of Choline Alfoscerate for Treating Mild Depression in Elderly Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • CHOLINE ALFOSCERATE
    Italy

  • Study on Avelumab and Cetuximab for Patients with Metastatic Colorectal Cancer Who Have Previously Received Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Avelumab
    • Cetuximab
    Italy

  • Study on the Effectiveness and Safety of Budesonide and Prednisone for Children with Primary IgA Nephropathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Budesonide
    • Prednisone
    Poland

  • Study on Methylphenidate for Reducing Fatigue in Childhood Brain Tumor Survivors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cancer fatigue
    Investigated Drugs:
    • METHYLPHENIDATE
    • Placebo
    Denmark

  • Exploring Precision Dosing of Infliximab for Patients with Steroid-Resistant Severe Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Infliximab
    Belgium
Previous Page
1 … 287 288 289 290 291 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!